368 related articles for article (PubMed ID: 15821959)
1. CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.
Vlachou S; Nomikos GG; Panagis G
Psychopharmacology (Berl); 2005 May; 179(2):498-508. PubMed ID: 15821959
[TBL] [Abstract][Full Text] [Related]
2. WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation.
Vlachou S; Nomikos GG; Panagis G
Behav Brain Res; 2003 May; 141(2):215-22. PubMed ID: 12742258
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
[TBL] [Abstract][Full Text] [Related]
4. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
Vlachou S; Nomikos GG; Panagis G
Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
[TBL] [Abstract][Full Text] [Related]
5. Diuretic effects of cannabinoids.
Paronis CA; Thakur GA; Bajaj S; Nikas SP; Vemuri VK; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2013 Jan; 344(1):8-14. PubMed ID: 23019138
[TBL] [Abstract][Full Text] [Related]
6. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
De Vry J; Jentzsch KR
Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
[TBL] [Abstract][Full Text] [Related]
7. Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents.
Vlachou S; Nomikos GG; Stephens DN; Panagis G
Behav Pharmacol; 2007 Jul; 18(4):311-9. PubMed ID: 17551324
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice.
Grim TW; Wiebelhaus JM; Morales AJ; Negus SS; Lichtman AH
Drug Alcohol Depend; 2015 May; 150():31-7. PubMed ID: 25772438
[TBL] [Abstract][Full Text] [Related]
9. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
Katsidoni V; Kastellakis A; Panagis G
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
[TBL] [Abstract][Full Text] [Related]
10. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
Gerdeman G; Lovinger DM
J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
[TBL] [Abstract][Full Text] [Related]
11. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
Smith SR; Terminelli C; Denhardt G
J Pharmacol Exp Ther; 2000 Apr; 293(1):136-50. PubMed ID: 10734163
[TBL] [Abstract][Full Text] [Related]
12. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.
Manzanedo C; Rodríguez-Arias M; Daza-Losada M; Maldonado C; Aguilar MA; Miñarro J
Behav Brain Funct; 2010 Mar; 6():19. PubMed ID: 20307280
[TBL] [Abstract][Full Text] [Related]
13. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
McMahon LR; Koek W
Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
[TBL] [Abstract][Full Text] [Related]
14. Influence of the CB(1) receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2002 Jun; 136(4):581-7. PubMed ID: 12055136
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
[TBL] [Abstract][Full Text] [Related]
16. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
[TBL] [Abstract][Full Text] [Related]
18. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid modulation of electrically evoked pH and oxygen transients in the nucleus accumbens of awake rats.
Cheer JF; Wassum KM; Wightman RM
J Neurochem; 2006 May; 97(4):1145-54. PubMed ID: 16686693
[TBL] [Abstract][Full Text] [Related]
20. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats.
Pattij T; Janssen MC; Schepers I; González-Cuevas G; de Vries TJ; Schoffelmeer AN
Psychopharmacology (Berl); 2007 Jul; 193(1):85-96. PubMed ID: 17387457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
